Medindia LOGIN REGISTER
Medindia

Salt Intake Linked to CVD Risk in Patients With Chronic Kidney Disease

by Shirley Johanna on May 25 2016 7:27 PM

The risk of cardiovascular disease increased in individuals with the highest urinary sodium excretion independent of several important CVD risk factors.

Salt Intake Linked to CVD Risk in Patients With Chronic Kidney Disease
Researchers at the Tulane University School of Public Health and Tropical Medicine, New Orleans, evaluated more than 3,500 participants with chronic kidney disease (CKD), examining the association between urinary sodium excretion and clinical cardiovascular disease (CVD) events.
Chronic kidney disease affects approximately 11 percent of the U.S. population and is associated with increased risk of CVD and all-cause mortality. Greater than 1 in 3 U.S. adults has CVD, and it is the leading cause of death in the United States. A positive association between sodium intake and blood pressure is well established. However, the association between sodium intake and clinical CVD remains less clear, and this relationship has not been investigated in patients with CKD.

This study included 3,757 patients with CKD from 7 locations in the U.S. enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study and were followed up from May 2003 to March 2013. Participants were requested to provide urine specimens at study entry and the first 2 annual follow-up visits. Among the participants (average age, 58 years; 45 percent women), 804 composite CVD events (congestive heart failure, stroke, or heart attack) occurred during a median 6.8 years of follow-up.

The researchers found a significantly increased risk of CVD in individuals with the highest urinary sodium excretion independent of several important CVD risk factors, including use of antihypertensive medications and history of CVD. The cumulative incidence of CVD events in the highest quartile of calibrated sodium excretion compared with the lowest was 23.2 percent vs 13.3 percent for heart failure, 10.9 percent vs 7.8 percent for heart attack, and 6.4 percent vs 2.7 percent for stroke at median follow-up.

Findings were consistent across subgroups and independent of further adjustment for total caloric intake and systolic blood pressure.

"These findings, if confirmed by clinical trials, suggest that moderate sodium reduction among patients with CKD and high sodium intake may lower CVD risk," the authors write. The study is published in JAMA

Source-Eurekalert


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education